Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Wenhua Zhan
Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer
Frontiers in Pharmacology
Pharmacology
Related publications
Doxorubicin and ABT-199 Coencapsulated Nanocarriers for Targeted Delivery and Synergistic Treatment Against Hepatocellular Carcinoma
Journal of Nanomaterials
Materials Science
Nanotechnology
Nanoscience
Synergistic Effect of Geranylgeranyltransferase Inhibitor, GGTI, and Docetaxel on the Growth of Prostate Cancer Cells
Prostate Cancer
Cancer Research
Oncology
Urology
Synergistic Effect of a Retinoid X Receptor-Selective Ligand Bexarotene and Docetaxel in Prostate Cancer [Corrigendum]
OncoTargets and Therapy
Oncology
Pharmacology
Synergistic Induction of Apoptosis in Brain Cancer Cells by Targeted Codelivery of siRNA and Anticancer Drugs
Molecular Pharmaceutics
Drug Discovery
Molecular Medicine
Pharmaceutical Science
Pharmacogenomic Biomarkers in Docetaxel Treatment of Prostate Cancer: From Discovery to Implementation
Genes
Genetics
Clinical Study of Long-Term Docetaxel Based Chemotherapy Treatment for Patients With Castration-Resistant Prostate Cancer
Japanese Journal of Urology
Urology
Cytosolic Co-Delivery of miRNA-34a and Docetaxel With Core-Shell Nanocarriers via Caveolae-Mediated Pathway for the Treatment of Metastatic Breast Cancer
Scientific Reports
Multidisciplinary
‘Charting a New Course for Prostate Cancer’ – Currying Favor for Docetaxel in Hormone-Sensitive Metastatic Prostate Cancer
Expert Review of Anticancer Therapy
Oncology
Pharmacology
Salvage Therapy for Castration-Refractory Prostate Cancer Resistant to Docetaxel
Japanese Journal of Urology
Urology